Colorectal cancer patients with high risk of hematogenous metastasis: Correlation with CEA levels in peripheral and draining venous blood during the period of operation
Corresponding Author
Yoshiki Tabuchi MD, PhD
School of Allied Medical Sciences, Kobe University, Kobe, Japan
School of Allied Medical Sciences, Kobe University, Tomogaoka 7-10-2, Suma-ku, Kobe 654-01, JapanSearch for more papers by this authorHiroyuki Deguchi MD
Department of Surgery, Kobe University School of Medicine, Kobe, Japan
Search for more papers by this authorKizuki Imanishi MD
Department of Surgery, Kobe University School of Medicine, Kobe, Japan
Search for more papers by this authorYoichi Saitoh MD, PhD
Department of Surgery, Kobe University School of Medicine, Kobe, Japan
Search for more papers by this authorCorresponding Author
Yoshiki Tabuchi MD, PhD
School of Allied Medical Sciences, Kobe University, Kobe, Japan
School of Allied Medical Sciences, Kobe University, Tomogaoka 7-10-2, Suma-ku, Kobe 654-01, JapanSearch for more papers by this authorHiroyuki Deguchi MD
Department of Surgery, Kobe University School of Medicine, Kobe, Japan
Search for more papers by this authorKizuki Imanishi MD
Department of Surgery, Kobe University School of Medicine, Kobe, Japan
Search for more papers by this authorYoichi Saitoh MD, PhD
Department of Surgery, Kobe University School of Medicine, Kobe, Japan
Search for more papers by this authorAbstract
Correlations between carcinoembryonic antigen (CEA) levels of peripheral (p) and draining (d) venous blood during the period of operation, and pre- and post-operatively detected hematogenous metastases were examined in 78 patients with colorectal cancer. The metastases were found in 28 patients (HM group), but not found in the other 50 patients (non-HM group). The mean values (43 and 198 ng/ml) and positive rates (61 and 96%) greater than 5 ng/ml of p- and d-CEA levels in the HM group were significantly higher than those (6 and 14 ng/ml, and 22 and 48%, respectively) in the non-HM group. The differences (mean 184 ng/ml and positive rate 49%) of d-CEA levels between both groups were more significant than those (39 ng/ml and 30%) of p-CEA levels. The mean value (155 ng/ml) and positive rate (82%) greater than 5 ng/ml of the gradient between d- and p-CEA levels (d-p CEA gradient) in the HM group were significantly higher than those (8 ng/ml and 34%) in the non-HM group. These results suggest that patients with a high risk of hematogenous metastases are more effectively checked by the determination of d-CEA levels and d-p CEA gradient than of p-CEA levels, and that they are patients with positive d-CEA and d-p CEA gradient levels.
References
- 1
Freedman LS,
Macaskill P,
Smith AN:
Multivariate analysis of prognostic factors for operable rectal cancer.
Lancet
29:
733–736,
1984.
10.1016/S0140-6736(84)92636-9 Google Scholar
- 2 Chapuis PH, Dent OF, Fisher R, Newland RC, Pheils MT, Smyth E, Colquhounk K: A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel. Br J Surg 72: 698–702, 1985.
- 3 Jass JR, Atkin WS, Cuzick J, Bussey HJR, Morson BC, Northover JMA, Todd IP: The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology 10: 437–459, 1986.
- 4 Maruoka Y, Maetani S, Tobe Y: Statistical analysis of pathological factors in influencing prognosis of colorectal carcinoma. Jpn J Surg 89: 181–191, 1988.
- 5 Mach JP, Jaeger P, Bertholet MM: Detection of recurrence of large bowel carcinoma by radioimmunoassay of circulating carcinoembryonic antigen (CEA). Lancet 2: 535–540, 1974.
- 6 Mackay AM, Patel S, Carter S, Stevens U, Laurence DJR, Cooper EM, Neville AM: Role of serial plasma CEA assays in detection of recurrent and metastatic colorectal carcinomas. Br Med J [Clin Res] 4: 382–385, 1974.
- 7 Bivins BA, Meeker WR, Griffen WO, Pellegrini J, Parker JC: Carcinoembryonic antigen (CEA) levels and histology in colon cancer. J Surg Res 18: 257–261, 1975.
- 8 Zamcheck N, Doos WG, Prudente R, Rurie BB, Gottlieb LS: Prognostic factors in colon carcinoma: correlation of carcinoembryonic antigen levels and tumor histopathology. Hum Pathol 6: 31–45, 1975.
- 9 Herrera M, Chu TM, Holyoke ED: Carcinoembryonic antigen (CEA) as a prognostic and monitoring test in circulating complete resection of colorectal cancer. Ann Surg 183: 5–9, 1976.
- 10 Sugarbaker PH, Skiarin AT, Zamcheck N: Pattern of serial CEA assays and their clinical use in management of colorectal cancer. J Surg Oncol 8: 523–537, 1976.
- 11
Martin EW,
James KK,
Hurtbise PE,
Catlano P,
Minton JP:
The use of CEA as an early indicator for gastrointestinal tumor recurrence and second-look procedures.
Cancer
39:
440–446,
1977.
10.1002/1097-0142(197702)39:2<440::AID-CNCR2820390212>3.0.CO;2-6 PubMed Web of Science® Google Scholar
- 12 Wanebo HJ, Sterns H, Schwarz MK: Use of CEA as an indicator of early recurrence and as a guide to selected second look procedure in patients with colorectal cancer. Ann Surg 188: 481–493, 1978.
- 13 Staab HJ, Anderer FA, Stumpf E, Fisher R: Slope analysis of the postoperative CEA time course and its possible application as an aid in diagnosis of disease progression in gastrointestinal cancer. Am J Surg 136: 322–327, 1978.
- 14 Martin EWJr, Cooperman M, Carly LC, Milton JP: Sixty second-look procedures indicated primarily by rise in serial carcinoembryonic antigen. J Surg Res 28: 389–394, 1980.
- 15 Goldenberg DM, Neville M, Carter AC, Go WLM, Holyoke ED, Isselbacher KJ, Schlein PS, Schwartz M: Carcinoembryonic antigen: its role as a marker in the management of cancer. A National Institute of Health Consensus Development Conference. Ann Intern Med 94: 402–409, 1981.
- 16 Wagener C, Wallraf RM, Nisson S, Groner J, Beuer H: Localization and concentration of carcinoembryonic antigen (CEA) in gastrointestinal tumor: correlation with CEA levels in plasma. JNCI 67: 539–547, 1981.
- 17
Attiyeh FF,
Sterns MW Jr:
Second-look laparotomy based on CEA elevations in colorectal cancer.
Cancer
47:
2119–2125,
1981.
10.1002/1097-0142(19810501)47:9<2119::AID-CNCR2820470903>3.0.CO;2-7 CAS PubMed Web of Science® Google Scholar
- 18 Go WLM, Zamcheck N: The role of tumor markers in the management of colorectal cancer. Cancer 50: 2618–2623, 1982.
- 19 Finlay IG, McArdle CS: Role of carcinoembryonic antigen of asymptomatic disseminated disease in colorectal carcinoma. Br Med J [Clin Res] 286: 1242–1244, 1983.
- 20 Walmark KN, Fisher B, Wieland HS, Henry RS, Lerner H, Legault-Poisson S, Deckers P, Dimitrov N, Gordon PH, Jochimsen P, Oischi N: The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer. Results from NSABP clinical trials. Ann Surg 199: 375–382, 1984.
- 21 Gold P, Freedman SO: Specific carcinoembryonic antigens of the human digestive system. J Exp Med 122: 467–481, 1965.
- 22 Deguchi H, Tabuchi Y, Saitoh Y: CEA levels of draining venous blood and draining-peripheral CEA gradient in colorectal cancer patients: correlation with postoperative survival. Jpn J Surg 91: 575–580, 1990 (in Japanese with English abstract).
- 23
Deguchi H,
Tabuchi Y,
Imanishi K,
Saitoh Y:
Correlation of carcinoembryonic antigen (CEA) levels in draining venous blood and draining-peripheral CEA gradient, and postoperative survival of gastric cancer patients.
Jpn J Gastroenterol Surg
23:
2185–2190,
1990 (in Japanese with English abstract).
10.5833/jjgs.23.2185 Google Scholar
- 24
Tabuchi Y,
Deguchi H,
Imanishi K,
Saitoh Y:
Comparison of carcinoembryonic antigen levels between portal and peripheral blood in patients with colorectal cancer. Correlation with histopathologic variables.
Cancer
59:
1283–1288,
1987.
10.1002/1097-0142(19870401)59:7<1283::AID-CNCR2820590709>3.0.CO;2-G CAS PubMed Web of Science® Google Scholar
- 25
Tabuchi Y,
Deguchi H,
Saitoh Y:
Carcinoembryonic antigen and carbohydrate antigen 19-9 levels of peripheral and draining venous blood in colorectal cancer patients.
Cancer
62:
1605–1613,
1988.
10.1002/1097-0142(19881015)62:8<1605::AID-CNCR2820620825>3.0.CO;2-V CAS PubMed Web of Science® Google Scholar
- 26 Tabuchi Y, Deguchi H, Saitoh Y: Carcinoembryonic antigen levels of portal blood in gastric cancer patients. J Surg Res 47: 81–86, 1989.
- 27 Moore TL, Kantrowitz PA, Zamcheck N: Carcinoembryonic antigen assay in inflammatory bowel disease. JAMA 222: 944–947, 1972.
- 28 Hirai H: Collaborative clinical study of carcinoembryonic antigen in Japan. Cancer Res 37: 2267–2274, 1977.
- 29 Putzki H, Ledwoch J, Student A, Jablonski M, Heymann H: Tumor markers carcinoembryonic antigen, tissue polypeptide antigen, and carbohydrate antigen 19/9 in liver diseases. J Surg Oncol 37: 133–135, 1988.
- 30 Thomas P, Zamcheck N: Role of the liver in clearance and excretion of circulating carcinoembryonic antigen (CEA). Dig Dis Sci 28: 216–224, 1983.
- 31 Martin KW, Halpern SE: Carcinoembryonic antigen production, secretion and kinetics in BALB/c mice and a nude mouse-human tumor model. Cancer Res 44: 5475–5481, 1984.
- 32
Hamada Y,
Yamamura K,
Hioki K,
Yamamoto M,
Nagura H,
Watanabe K:
Immunohistochemical study of carcinoembryonic antigen in patients with colorectal cancer. Correlation with plasma carcinoembryonic antigen levels.
Cancer
55:
136–141,
1985.
10.1002/1097-0142(19850101)55:1<136::AID-CNCR2820550121>3.0.CO;2-P CAS PubMed Web of Science® Google Scholar
- 33 Shuster J, Silverman M, Gold P: Metabolism of human carcinoembryonic antigen in xenogenic animals. Cancer Res 33: 65–68, 1973.
- 34 Sugarbaker PH: Carcinoembryonic antigen (CEA) assay in obstructive colorectal cancer. Ann Surg 184: 752–757, 1976.
- 35 Staab HJ, Anderer FA, Stumpf E, Fisher R: Retidivprognosen bei Patienten mit Adenokarzinomen des Gastrointestinal-traktes auf der Basis von Carcinoembryonalen Antigen (CEA) und seinen zirculierendes Immunokomplexen. Klin Wochenshr 58: 125–133, 1980.